NCT02732821

Brief Summary

This study is performed to assess the efficacy and outcomes of Gastric Per Oral Endoscopic Myotomy "G-POEM" in patients presenting with gastroparesis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 30, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 11, 2016

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

August 21, 2020

Status Verified

August 1, 2020

Enrollment Period

4.9 years

First QC Date

March 30, 2016

Last Update Submit

August 19, 2020

Conditions

Keywords

GastroparesisG-POEMGastric Per Oral Endoscopic Myotomy

Outcome Measures

Primary Outcomes (1)

  • Efficacy of the G-POEM

    Improvement in patients symptoms as evaluated by the Gastroparesis Cardinal Symptom Index (GCSI) at 1 month, 3 months, 6 months and 1 year. The GCSI consists of three sub-scales: nausea/vomiting (three items), post-prandial fullness/early satiety (four items) and bloating (two items). Each item is rated on a Likert scale ranging from 0 (none) to 5 (very severe). Subscales are the average of different sets of items and are reported as a number between 0 to 5. Efficacy will be defined as a decrease in the GCSI score average below 2.

    Up to 1 year

Secondary Outcomes (4)

  • Patient symptom improvement

    Up to 1 year

  • Delayed gastric emptying using a Gastric emptying study

    3 months

  • Imapct of the G-POEM on patients' Quality of life

    Up to 1 year

  • Efficacy of the G-POEM

    1 year

Study Arms (1)

Gastric Per Oral Endoscopic Myotomy

All patients presenting with Gastroparesis will undergo Per oral endoscopic gastric myotomy

Procedure: Gastric Per Oral Endoscopic Myotomy

Interventions

Patients will receive Per Oral Endoscopic Gastric Myotomy for Gastroparesis.

Gastric Per Oral Endoscopic Myotomy

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Individuals who initially approach the study team from outside the institution (e.g. responding to the clinicaltrials.gov listing) or patients seen in the gastroenterology clinic.

You may qualify if:

  • Adult patient age greater than 18 years old who are undergoing a standard-of-care G-POEM procedure.

You may not qualify if:

  • Previous surgery of the esophagus or stomach which has resulted in a resection of the antrum and pylorus
  • Known active gastroesophageal malignancy
  • Prior surgical or laparoscopic pyloromyotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

Location

Related Publications (1)

  • Vosoughi K, Ichkhanian Y, Benias P, Miller L, Aadam AA, Triggs JR, Law R, Hasler W, Bowers N, Chaves D, Ponte-Neto AM, Draganov P, Yang D, El Halabi M, Sanaei O, Brewer Gutierrez OI, Bulat RS, Pandolfino J, Khashab M. Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut. 2022 Jan;71(1):25-33. doi: 10.1136/gutjnl-2020-322756. Epub 2021 Mar 19.

MeSH Terms

Conditions

Gastroparesis

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mouen A Khashab, MD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2016

First Posted

April 11, 2016

Study Start

May 1, 2015

Primary Completion

April 1, 2020

Study Completion

April 1, 2020

Last Updated

August 21, 2020

Record last verified: 2020-08

Locations